Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenghua Decoction (Sheng-Hua-Tang) is a traditional Chinese herbal formula widely utilized in East Asian medicine for postpartum recovery. The standard formulation consists of five botanical ingredients: *Angelica sinensis* (Dang Gui), *Ligusticum chuanxiong* (Chuan Xiong), *Prunus persica* (Tao Ren), *Zingiber officinale* (charred ginger), and *Glycyrrhiza uralensis* (licorice). It is traditionally indicated to promote uterine involution, facilitate the discharge of lochia, and alleviate postpartum pain by "activating blood" and "resolving stasis." Clinical investigations, such as those conducted at Far Eastern Memorial Hospital, have examined its physiological effects on the uterus and its potential association with adverse events like delayed postpartum hemorrhage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shenghua decoction.